Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Drug-induced hperpigemntation: a systematic review.

Krause W.

J Dtsch Dermatol Ges. 2013 Jul;11(7):644-51. doi: 10.1111/ddg.12042. Epub 2013 May 8. Review.

PMID:
23650908
2.

Association of skin hyperpigmentation and drug use: a systematic review.

Krause W.

G Ital Dermatol Venereol. 2016 Dec;151(6):694-699. Epub 2016 Jun 1. Review.

PMID:
27248149
3.

Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review.

Talat B, Mayers A, Baldwin DS.

Hum Psychopharmacol. 2013 Sep;28(5):413-20. doi: 10.1002/hup.2329. Epub 2013 Jun 11. Review.

PMID:
23754771
4.

Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2011;11(1):1-93. Epub 2011 Feb 1.

5.

Endovascular laser therapy for varicose veins: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(6):1-92. Epub 2010 Apr 1.

6.

Minocycline for acne vulgaris: efficacy and safety.

Garner SE, Eady EA, Popescu C, Newton J, Li WA.

Cochrane Database Syst Rev. 2003;(1):CD002086. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002086.

PMID:
12535427
7.

A review and assessment of drug-induced parotitis.

Brooks KG, Thompson DF.

Ann Pharmacother. 2012 Dec;46(12):1688-99. doi: 10.1345/aph.1R228. Epub 2012 Dec 18. Review.

PMID:
23249870
8.

Bone graft substitutes for the treatment of traumatic fractures of the extremities.

Hagen A, Gorenoi V, Schönermark MP.

GMS Health Technol Assess. 2012;8:Doc04. doi: 10.3205/hta000102. Epub 2012 Jun 14.

9.

A 6-month prospective survey of cutaneous drug reactions in a hospital setting.

Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, Descamps V.

Br J Dermatol. 2003 Nov;149(5):1018-22.

PMID:
14632808
10.

[Skin adverse effects of amiodarone].

Zgazarová S, Jedlicková H, Vasků V.

Vnitr Lek. 2009 Oct;55(10):976-80. Review. Czech.

PMID:
19947243
11.

Fixed drug eruptions. Incidence, recognition, and avoidance.

Lee AY.

Am J Clin Dermatol. 2000 Sep-Oct;1(5):277-85. Review.

PMID:
11702319
12.
13.
14.

Epidemiology of drug-induced severe skin reactions.

Mockenhaupt M, Schöpf E.

Semin Cutan Med Surg. 1996 Dec;15(4):236-43. Review.

PMID:
9069591
15.

Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.

Young TN, Arens FJ, Kennedy GE, Laurie JW, Rutherford Gw.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002835. Review.

PMID:
17253483
16.

The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.

Olivier P, Montastruc JL.

Pharmacoepidemiol Drug Saf. 2006 Nov;15(11):808-12.

PMID:
16700082
17.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, Lühmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

18.

Safety of doxycycline and minocycline: a systematic review.

Smith K, Leyden JJ.

Clin Ther. 2005 Sep;27(9):1329-42. Review.

PMID:
16291409
19.

Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid.

Ozog DM, Gogstetter DS, Scott G, Gaspari AA.

Arch Dermatol. 2000 Sep;136(9):1133-8.

PMID:
10987869
20.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117

Supplemental Content

Support Center